Home
›
BridgeBio Oncology Therapeutics, Inc.
› 424B3 Aug 12, 2026
BridgeBio Oncology Therapeutics, Inc. (BBOT): 424B3 filed Aug 12, 2026
Form type
424B3
Filing date
Aug 12, 2026
Accession number
0001193125-26-345123
Filer
BridgeBio Oncology Therapeutics, Inc.
(CIK 1869105)